| ID | Analyse | Domein | Recipiënt | Uitvoering | LTAT (uren (dagen)) | Accred. | LOINCeenheid (1) | LOINCeenheid (2) | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 22585 | Hemoglobine A1c niet-diab Fast hemoglobine, Glycohemoglobine, HbA1c | EDTA |
1 (0) | – | 4548-4 | – | › | |||
| 3008 | Hemopexine | Serum |
tenminste 1× per week | – | 2403-4 g/l | – | › | |||
| 80665 | Hep.B PCR kwant. HBV DNA kwantitatief, Hepatitis B PCR | EDTA |
76 (3,2) | – | – | – | › | |||
| 80535 | Hep.C PCR kwalit. HCV kwalitatief, HCV RNA, Hepatitis C PCR | EDTA |
60 (2,5) | – | – | – | › | |||
| 80575 | Hep.C PCR kwant. HCV kwantitatief, HCV RNA, Hepatitis C PCR | EDTA |
97 (4) | – | – | – | › | |||
| 80660 | Hepatit.B pcr opflakkeren HBV DNA kwantitatief, Hepatitis B PCR | EDTA |
23 (1) | – | – | – | › | |||
| 80655 | Hepatit.B PCR opvolging HBV DNA kwantitatief, Hepatitis B PCR | EDTA |
98 (4,1) | – | – | – | › | |||
| 80650 | Hepatit.B PCR voor start HBV DNA kwantitatief, Hepatitis B PCR | EDTA |
74 (3,1) | – | – | – | › | |||
| 24503 | Hepatitis A As (totaal) HAVAB | Serum |
maandag t/m vrijdag | 2 (0,1) | B | 22312-3 Index | 32018-4 Index | › | ||
| 24501 | Hepatitis A IgM (recent) HAV IgM antistoffen | Serum |
maandag t/m vrijdag | 2 (0,1) | B | 22315-6 Index | 22314-9 Index | › | ||
| 24466 | Hepatitis B core As HBcAs | Serum |
maandag t/m vrijdag | 2 (0,1) | B | 16933-4 Index | – | › | ||
| 24462 | Hepatitis B e antigeen HBeAg | Serum |
maandag t/m vrijdag | 2 (0,1) | B | 31844-4 Index | – | › | ||
| 24460 | Hepatitis B surface Ag Australia antigeen, HBsAg | Serum |
maandag t/m vrijdag | 2 (0,1) | B | 5195-3 Index | – | › | ||
| 24493 | Hepatitis B surface As HBV surface antistoffen | Serum |
maandag t/m vrijdag | 2 (0,1) | B | 16935-9 mIU/mL | – | › | ||
| 24464 | Hepatitis Be antistoffen HBeAs | Serum |
maandag t/m vrijdag | 3 (0,1) | B | 22320-6 Index | – | › | ||
| 24507 | Hepatitis C antistoffen HCV antistoffen, HCV As | Serum |
maandag t/m vrijdag | 2 (0,1) | B | 16128-1 Index | – | › | ||
| 4533 | Hepatitis E antistoffen | Serum |
14 (0,6) | – | 35680-8 | – | › | |||
| 8531 | HERDA | EDTA |
142 (5,9) | – | – | – | › | |||
| 1404 | Heredit. hemochromatose | EDTA |
– | – | – | › | ||||
| 4759 | Herpes Aviair | Serum |
1× per 2 weken | – | – | – | › | |||
| 69592 | Herpes simplex 1-2 DNA HSV 1-2 DNA | eSwab (Wissers varia / Overig) |
72 (3) | – | 91857-3 | – | › | |||
| 24662 | Herpes simplex IgG HSV IgG | Serum |
2× per week | 85 (3,5) | B | 31411-2 RU/mL | – | › | ||
| 24660 | Herpes simplex IgM HSV IgM | Serum |
2× per week | 87 (3,6) | B | 43030-6 index | – | › | ||
| 69632 | Herpes simplex PCR(vocht) | Varia / Diversen |
82 (3,4) | – | – | – | › | |||
| 8467 | Herpesvirus koi | Varia / Diversen |
– | – | – | › | ||||
| 57680 | Hexanol /g creatinine | Urine |
306 (12,7) | – | – | – | › | |||
| 3415 | Hexokinase | EDTA |
2× per week | – | 49216-5 U/g Hb | – | › | |||
| 57750 | Hippuurzuur /g creatinine | Urine |
304 (12,7) | – | – | – | › | |||
| 24721 | HIV-1/2 (Ag+Ab) Humaan immunodeficiëntievirus-1/2 (Ag+As) | Serum |
maandag t/m vrijdag | 2 (0,1) | B | 56888-1 Index | – | › | ||
| 80690 | HIV pcr | EDTA |
92 (3,8) | – | 9836-8 | – | › | |||
| 4727 | HIV VIRALE LADING Humaan immunodeficiëntievirus virale lading | EDTA |
172 (7,2) | – | – | – | › | |||
| 1459 | HLA-DQB1/DRB1 (narcolep) | EDTA |
1× per 2 weken | – | – | – | › | |||
| 21442 | HLA B27 PCR Humaan Leucocyten Antigeen B27 typering | EDTA |
maandag t/m vrijdag | 74 (3,1) | – | 4821-5 | – | › | ||
| 23311 | HMGCR 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase as (IgG), HMG-CoA reductase antistoffen (IgG) | Serum |
1× per week | 175 (7,3) | – | 93493-5 U/mL | – | › | ||
| 52646 | Homocysteïne | Homocysteïne |
maandag t/m vrijdag | 3 (0,1) | – | 13965-9 µmol/L | – | › | ||
| 7035 | Homogentisinezuur | Urine |
– | 2433-1 | – | › | ||||
| 4752 | Hondeziekte Carré-Distemper antistoffen | Serum |
4× per week | 255 (10,6) | – | – | – | › | ||
| 4397 | Hondeziekte PCR Canine distemper virus PCR | Speciale afname |
3× per week | 121 (5) | – | – | – | › | ||
| 30103 | HPV + Cytologie Cervixuitstrijkje (dunnelaag cytologie) - Preventief, Human Papillomavirus, Papsmear (dunnelaag cytologie) - Preventief | ThinPrep (Cervix- / Vloeistofcytologie) |
258 (10,7) | – | – | – | › | |||
| 30100 | HPV buiten RIZIV Human Papillomavirus | 166 (6,9) | – | – | – | › | ||||
| 30145 | HPV d1 | 333 (13,9) | – | – | – | › | ||||
| 30146 | hpv d2 | 381 (15,9) | – | – | – | › | ||||
| 89034 | HPV moleculaire Biologie | – | – | – | › | |||||
| 30127 | HPV+cyto buiten RIZIV Cervixuitstrijkje (dunnelaag cytologie) - Buiten RIZIV, Human Papillomavirus, Papsmear (dunnelaag cytologie) - Buiten RIZIV | ThinPrep (Cervix- / Vloeistofcytologie) |
245 (10,2) | – | – | – | › | |||
| 29780 | hpvabb Kwalitatieve Hoog-Risico Humaan Papillomavirus DNA L1 | – | – | – | › | |||||
| 89033 | hpvmol2 | 116 (4,8) | – | – | – | › | ||||
| 22444 | Hs Troponine I | Serum |
maandag t/m vrijdag | 6 (0,3) | – | 89579-7 ng/L | – ng/mL | › | ||
| 24585 | HSV type 1-2 immunoblot Herpes simplex IgG type 1, Herpes simplex IgG type 2, HSV IgG type 1-2 differentiatie | Serum |
257 (10,7) | – | 81621-5 | – | › | |||
| 4721 | HTLV (I+II) antistoffen Humaan T-Lymfotroop virus antistoffen | Serum |
107 (4,5) | – | 31431-0 | – | › | |||
| 23226 | Huid (1/10) Anti-huid antistoffen, Basale membraan van de huid antistoffen, Keratinocyten antistoffen | Serum |
3× per week | 228 (9,5) | – | 66881-4 | – | › |
